Breast Cancer Recurrence in the Liver Mimicking Cirrhosis
This breast cancer diagnosis at a glance
- Stage at diagnosis
- Stage IV
- Biomarkers
- Original cancer: HER2-negative and PR-positive (30%). Liver recurrence: ER-positive.
- Sex
- Female
- Spread to
- liver
- Treatment
- chemotherapy, surgery, hormone therapy and supportive care
- Outcome
- In Memory
Treatment course, step by step
- Four cycles of neoadjuvant FEC-T chemotherapy were completed.
- Mastectomy with axillary clearance was performed.
- Tamoxifen was taken for one year.
- Tamoxifen was changed to anastrozole for four further years.
- Endocrine therapy was restarted after metastatic recurrence was diagnosed.
- Therapeutic paracentesis was performed for ascites.
- Video-assisted thoracoscopic pleurodesis was performed for refractory hydropneumothorax.
What happened, in summary
A 63-year-old woman developed progressive abdominal swelling, abnormal liver tests, and shortness of breath 14 years after treatment for left breast cancer. Her original tumor was T2 G2 N1, HER2-negative, and progesterone-receptor positive. Seven of 21 lymph nodes had contained cancer. She had completed four cycles of neoadjuvant FEC-T, mastectomy with axillary clearance, and five years of hormone therapy, beginning with tamoxifen and changing to anastrozole after menopause. She was later discharged from follow-up with no evidence of recurrence.
At presentation, examination showed ascites and a firm right-upper-abdominal mass. Ultrasound and cross-sectional imaging showed a shrunken, irregular liver with numerous lesions, marked ascites, a large left pleural effusion, two right-lung lesions, and sclerotic vertebral lesions. The appearance initially suggested cirrhosis with multifocal primary liver cancer. Therapeutic paracentesis was performed while the diagnosis was investigated.
Liver biopsy instead showed ER-positive metastatic breast carcinoma without established cirrhosis, confirming recurrent breast cancer with pseudocirrhosis. Only the biopsy-confirmed liver involvement is recorded as a metastatic site. Endocrine therapy was restarted, but her condition deteriorated quickly. Refractory hydropneumothorax required video-assisted thoracoscopic pleurodesis, and she died from hepatorenal syndrome five weeks after the initial presentation. The case shows how extensive breast-cancer deposits can mimic cirrhosis and produce severe portal-hypertension complications after a long disease-free interval.
Where this story comes from
This is a lay summary of an account first published by PMC / PubMed Central. Read the original in full
How we source and attribute stories Accuracy and limitations
Collections this story belongs to
- Stage 4 Breast Cancer 295 stories
- Stage 4 ER Positive Breast Cancer 87 stories
- ER Positive Breast Cancer 242 stories
- Anastrozole for Breast Cancer 71 stories
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer